Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies

被引:1
|
作者
Kim, Youngchang [1 ,2 ]
Maltseva, Natalia [1 ,2 ]
Tesar, Christine [1 ,2 ]
Jedrzejczak, Robert [1 ,2 ]
Endres, Michael [1 ,2 ]
Ma, Heng [3 ]
Dugan, Haley L. [4 ]
Stamper, Christopher T. [4 ]
Chang, Changsoo [1 ,2 ]
Li, Lei [4 ]
Changrob, Siriruk [4 ]
Zheng, Nai-Ying
Huang, Min [4 ]
Ramanathan, Arvind [3 ]
Wilson, Patrick [5 ]
Michalska, Karolina [1 ,2 ]
Joachimiak, Andrzej [1 ,2 ,4 ]
机构
[1] Univ Chicago, Ctr Struct Biol Infect Dis, Consortium Adv Sci & Engn, Chicago, IL 60367 USA
[2] Argonne Natl Lab, Struct Biol Ctr, Xray Sci Div, Lemont, IL 60439 USA
[3] Argonne Natl Lab, Data Sci & Learning Div, Lemont, IL 60439 USA
[4] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60367 USA
[5] Weill Cornell Med, Gale & Ira Drukier Inst Childrens Hlth, New York, NY 10021 USA
关键词
PROTEIN; MODEL; REFINEMENT;
D O I
10.1016/j.isci.2024.108976
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Coronavirus nucleocapsid protein (NP) of SARS-CoV-2 plays a central role in many functions important for virus proliferation including packaging and protecting genomic RNA. The protein shares sequence, structure, and architecture with nucleocapsid proteins from betacoronaviruses. The N -terminal domain (NPRBD) binds RNA and the C -terminal domain is responsible for dimerization. After infection, NP is highly expressed and triggers robust host immune response. The anti -NP antibodies are not protective and not neutralizing but can effectively detect viral proliferation soon after infection. Two structures of SARSCoV-2 NPRBD were determined providing a continuous model from residue 48 to 173, including RNA binding region and key epitopes. Five structures of NPRBD complexes with human mAbs were isolated using an antigen -bait sorting. Complexes revealed a distinct complement -determining regions and unique sets of epitope recognition. This may assist in the early detection of pathogens and designing peptide -based vaccines. Mutations that significantly increase viral load were mapped on developed, full length NP model, likely impacting interactions with host proteins and viral RNA.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
    Yuan, Meng
    Liu, Hejun
    Wu, Nicholas C.
    Wilson, Ian A.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 192 - 203
  • [2] Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
    Ye, Qiaozhen
    Lu, Shan
    Corbett, Kevin D.
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes
    Lee, Jong-Hwan
    Jung, Yujin
    Lee, Sung-Kyun
    Kim, Jung
    Lee, Chang-Seop
    Kim, Soohyun
    Lee, Ji-Seon
    Kim, Nam-Hoon
    Kim, Hong-Gi
    [J]. VIRUSES-BASEL, 2022, 14 (02):
  • [4] Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
    Khan, Abbas
    Khan, Muhammad Tahir
    Saleem, Shoaib
    Junaid, Muhammad
    Ali, Arif
    Ali, Syed Shujait
    Khan, Mazhar
    Wei, Dong-Qing
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 (18): : 2174 - 2184
  • [5] Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
    Dinesh, Dhurvas Chandrasekaran
    Chalupska, Dominika
    Silhan, Jan
    Koutna, Eliska
    Nencka, Radim
    Veverka, Vaclav
    Boura, Evzen
    [J]. PLOS PATHOGENS, 2020, 16 (12)
  • [6] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Yu, Fei
    Xiang, Rong
    Deng, Xiaoqian
    Wang, Lili
    Yu, Zhengsen
    Tian, Shijun
    Liang, Ruiying
    Li, Yanbai
    Ying, Tianlei
    Jiang, Shibo
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [7] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Fei Yu
    Rong Xiang
    Xiaoqian Deng
    Lili Wang
    Zhengsen Yu
    Shijun Tian
    Ruiying Liang
    Yanbai Li
    Tianlei Ying
    Shibo Jiang
    [J]. Signal Transduction and Targeted Therapy, 5
  • [8] Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein
    Hodge, Curtis D.
    Rosenberg, Daniel J.
    Wilamowski, Mateusz
    Joachimiak, Andrzej
    Hura, Greg L.
    Hammel, Michal
    Grobc, Patricia
    [J]. MABS, 2021, 13 (01)
  • [9] Monoclonal antibodies binding data for SARS-CoV-2 proteins
    Mishra, Nawneet
    Teyra, Joan
    Boytz, RuthMabel
    Miersch, Shane
    Merritt, Trudy N.
    Cardarelli, Lia
    Gorelik, Maryna
    Mihalic, Filip
    Jemth, Per
    Davey, Robert A.
    Sidhu, Sachdev S.
    Leung, Daisy W.
    Amarasinghe, Gaya K.
    [J]. DATA IN BRIEF, 2022, 43
  • [10] Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein
    Anderson, George P.
    Liu, Jinny L.
    Esparza, Thomas J.
    Voelker, Bruce T.
    Hofmann, E. Randal
    Goldman, Ellen R.
    [J]. ANALYTICAL CHEMISTRY, 2021, 93 (19) : 7283 - 7291